Fresenius Medical Care AG
FMS
$22.06
-$0.05-0.20%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.03% | 8.88% | 9.13% | 6.00% | 0.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.03% | 8.88% | 9.13% | 6.00% | 0.16% |
| Cost of Revenue | 1.24% | 5.39% | 7.18% | 4.78% | 0.94% |
| Gross Profit | 8.64% | 19.34% | 15.26% | 9.77% | -2.21% |
| SG&A Expenses | 8.80% | 2.06% | -0.79% | 8.25% | -6.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 125.20% | -5.87% | 93.78% | 55.50% | 169.49% |
| Total Operating Expenses | 2.67% | 4.57% | 6.80% | 5.55% | -0.02% |
| Operating Income | 7.29% | 58.25% | 34.77% | 11.36% | 2.37% |
| Income Before Tax | -9.72% | 210.01% | 12.50% | 8.89% | 53.95% |
| Income Tax Expenses | -23.63% | 90.57% | -31.35% | -16.66% | 49.77% |
| Earnings from Continuing Operations | -5.24% | 271.69% | 31.86% | 19.41% | 55.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -34.18% | -59.79% | -9.64% | 7.17% | 21.42% |
| Net Income | -15.25% | 433.92% | 37.18% | 27.00% | 106.59% |
| EBIT | 7.29% | 58.25% | 34.77% | 11.36% | 2.37% |
| EBITDA | 4.70% | 39.58% | 19.16% | 5.30% | -1.92% |
| EPS Basic | -9.66% | 448.02% | 37.80% | 26.99% | 106.63% |
| Normalized Basic EPS | 7.40% | 66.24% | 55.29% | 25.21% | 24.80% |
| EPS Diluted | -9.66% | 467.89% | 37.68% | 26.99% | 108.21% |
| Normalized Diluted EPS | 7.40% | 66.24% | 55.29% | 25.21% | 24.80% |
| Average Basic Shares Outstanding | -6.19% | -2.56% | -0.45% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | -6.19% | -2.56% | -0.45% | 0.00% | 0.00% |
| Dividend Per Share | -- | 13.00% | -- | -- | -- |
| Payout Ratio | -- | -- | -- | 0.00% | -- |